Last $1.77 USD
Change Today +0.03 / 1.72%
Volume 461.9K
CRIS On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Douglas A. Melton Ph.D.

Former Director, Curis, Inc.
AgeTotal Calculated CompensationThis person is connected to 47 board members in 4 different organizations across 6 different industries.

See Board Relationships
60--

Background*

Dr. Douglas A. Melton, Ph.D., serves as Co-Chairman of the Department of Stem Cell and Regenerative Biology at Harvard University. Dr. Melton serves as the Thomas Dudley Cabot Professor of Natural Sciences at the Department of Molecular and Cellular Biology of Harvard University. He serves as an Investigator at the Howard Hughes Medical Institute and Co-Director of Harvard's Stem Cell Institute and Center for Genomics Research. Dr. Melton’s work focused on vertebrate ...

Read Full Background

Corporate Headquarters*

4 Maguire Road
Lexington, Massachusetts 02421

United States

Phone: 617-503-6500
Fax: 617-503-6501

Board Members Memberships*

2000-N/A
Former Director
2000-N/A
Former Director

Education*

PhD
University of Cambridge
BA
University of Cambridge
BS
University of Illinois-Urbana-Champaign

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRIS:US $1.77 USD +0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
$489.3K
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
$555.0K
Michael M. Goldberg M.D., M.B.A.Interim Chief Executive Officer and Director
Navidea Biopharmaceuticals, Inc
--
Rosemary A. Crane Chief Executive Officer, President and Director
MELA Sciences, Inc.
$43.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CURIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.